The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Samy Suissa

McGill Pharmacoepidemiology Research Unit

McGill University Health Centre





Name/email consistency: high



  • McGill Pharmacoepidemiology Research Unit, McGill University Health Centre, Montreal, Québec, Canada. 2008
  • Division of Clinical Epidemiology, McGill University Health Centre, Canada. 2008
  • Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre and the Department of Epidemiology and Biostatistics, McGill University, Que. 2000 - 2008
  • McGill Univerisity, Montreal, Canada. 2003 - 2006


  1. Methodological issues in therapeutic trials of COPD. Suissa, S., Ernst, P., Vandemheen, K.L., Aaron, S.D. Eur. Respir. J. (2008) [Pubmed]
  2. TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Suissa, S., Ernst, P., Hudson, M. Pulm. Pharmacol. Ther (2008) [Pubmed]
  3. Mortality benefit from unrestricted access to clopidogrel: too good to be true? Suissa, S. CMAJ (2008) [Pubmed]
  4. Immortal time bias in pharmaco-epidemiology. Suissa, S. Am. J. Epidemiol. (2008) [Pubmed]
  5. Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Suissa, S., Garbe, E. Nat. Clin. Pract. Rheumatol (2007) [Pubmed]
  6. Immortal time bias in observational studies of drug effects. Suissa, S. Pharmacoepidemiol. Drug. Saf (2007) [Pubmed]
  7. Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Suissa, S. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  8. Furosemide use and hospitalization for benign prostatic hyperplasia. Delaney, J.A., Lévesque, L.E., Etminan, M., Suissa, S. Can. J. Clin. Pharmacol (2006) [Pubmed]
  9. ACE-inhibitor use and the long-term risk of renal failure in diabetes. Suissa, S., Hutchinson, T., Brophy, J.M., Kezouh, A. Kidney Int. (2006) [Pubmed]
  10. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Suissa, S., Hudson, M., Ernst, P. Arthritis Rheum. (2006) [Pubmed]
  11. Antirheumatic drug use and the risk of acute myocardial infarction. Suissa, S., Bernatsky, S., Hudson, M. Arthritis Rheum. (2006) [Pubmed]
  12. Contribution of pharmacoepidemiological studies to the evaluation of treatment-related adverse events. Suissa, S. Joint. Bone. Spine (2006) [Pubmed]
  13. Bias in observational study of the effectiveness of nasal corticosteroids in asthma. Suissa, S., Ernst, P. J. Allergy Clin. Immunol. (2005) [Pubmed]
  14. Inhaled and nasal corticosteroid use and the risk of fracture. Suissa, S., Baltzan, M., Kremer, R., Ernst, P. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  15. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Suissa, S. Eur. Respir. J. (2004) [Pubmed]
  16. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Suissa, S., Ernst, P., Hudson, M., Bitton, A., Kezouh, A. Am. J. Med. (2004) [Pubmed]
  17. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Suissa, S., Assimes, T., Ernst, P. Thorax (2003) [Pubmed]
  18. Use of anti-inflammatory therapy and asthma mortality in Japan. Suissa, S., Ernst, P. Eur. Respir. J. (2003) [Pubmed]
  19. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Suissa, S. Am. J. Respir. Crit. Care Med. (2003) [Pubmed]
  20. Risk factors of poor prognosis after whiplash injury. Suissa, S. Pain. Res. Manag (2003) [Pubmed]
  21. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Suissa, S., Assimes, T., Brassard, P., Ernst, P. Am. J. Med. (2003) [Pubmed]
  22. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Suissa, S., Ernst, P., Kezouh, A. Thorax (2002) [Pubmed]
  23. The relation between initial symptoms and signs and the prognosis of whiplash. Suissa, S., Harder, S., Veilleux, M. Eur. Spine. J (2001) [Pubmed]
  24. Low-dose inhaled corticosteroids and the prevention of death from asthma. Suissa, S., Ernst, P., Benayoun, S., Baltzan, M., Cai, B. N. Engl. J. Med. (2000) [Pubmed]
WikiGenes - Universities